Latest News for: phase iii trial

Edit

New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings

Pharmiweb 26 Mar 2025
... and ADAURA Phase III trials, locally advanced stages in the LAURA Phase III trial and late-stage disease in the FLAURA and FLAURA2 Phase III trials. .
Edit

Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older

Pharmiweb 26 Mar 2025
The safety and tolerability profile of Blujepa in the EAGLE-2 and EAGLE-3 phase III trials was consistent with previous trials ... and are currently enrolling for PIVOT-PO, a phase III trial.
Edit

Colorectal Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 26 Mar 2025
Currently it is in Phase III stage of clinical trial evaluation to treat Colorectal Cancer ... Currently being evaluated in the Phase III studies ... Currently the drug is being evaluated in Phase III for the treatment of Colorectal Cancer.
Edit

Dementia Associated With Alzheimer’s Disease Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism ...

GetNews 26 Mar 2025
Currently, the drug is in Phase III stage of development for the treatment of Alzheimer Disease ... Currently, the drug is in Phase III stage of its clinical trial for the treatment of Dementia Associated With Alzheimer’s Disease.
Edit

Psilocybin: How Science Is Turning Magic Mushrooms Into Medicine

IFL Science 26 Mar 2025
A Phase II ... Two Phase III trials – which represent the final round of research before a regulatory submission package can be sent to the FDA – are now underway, and are expected to be completed in 2026.
Edit

New hope for UTI patients as FDA approves first-of-its-kind antibiotic in 30 years

Interesting Engineering 26 Mar 2025
Clinical trials and FDA approval. The approval of the new drug is based on positive results from the Phase III EAGLE-2 and EAGLE-3 trials. In two trials involving 3,000 adults and teens, Blujepa treated ...
Edit

First Patient Dosed in Immutep's TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer (Form 6-K) (Immutep Ltd)

Public Technologies 26 Mar 2025
First Patient Dosed in Immutep's TACTI-004 Phase III Trial ... Ina Nordman, who treated the first patient at Calvary Mater Newcastle Hospital in Australia, stated, "We are very excited to participate in this important Phase III trial.
Edit

Fosun Pharma Announces 2024 Annual Results

Knoxville Daily Sun 26 Mar 2025
The HER2-targeted innovative monoclonal antibody HLX22 for gastric cancer treatment and the novel endocrine therapy HLX78 (lasofoxifene) for breast cancer are currently under international multi-center Phase III clinical trials.
Edit

First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer

Nasdaq Globe Newswire 25 Mar 2025
... diseases, today announces the first patient has been successfully dosed in the Company’s pivotal TACTI-004 Phase III trial.
Edit

Diffuse Large B-cell Lymphoma Pipeline 2025: FDA Approvals, Therapies, Clinical Trials, and Latest Insights Unveiled ...

GetNews 25 Mar 2025
The company, which collaborates with biotech firms to advance novel therapeutics across all phases, highlights the promising progress of Phase III trials for Mosunetuzumab and Selinexor, particularly in patients with relapsed or refractory DLBCL.
Edit

Bladder Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 25 Mar 2025
Currently it is in Phase III stage of clinical trial for the treatment of Bladder Cancer ... Currently, the drug is being evaluated in the Phase III stage for Bladder Cancer ... Products (Phase III) UGN-102.
Edit

Urticaria Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Sanofi, ...

GetNews 25 Mar 2025
In September 2024, Regeneron Pharmaceuticals and Sanofi reported that the confirmatory Phase III trial (LIBERTY-CUPID Study C) for Dupixent (dupilumab) successfully achieved its primary and key secondary endpoints ... Late-stage products (Phase III).
Edit

Asthma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, ...

GetNews 25 Mar 2025
GSK3511294 is currently being investigated in Phase III stage of Clinical trial evaluation for the treatment of Asthma ... Analytical Perspective Late Stage Products (Phase III) GSK3511294.
Edit

Breast Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 25 Mar 2025
Currently, the drug is in the Phase III stage of its development for the treatment of Breast Cancer ... Currently, the drug is in the Phase III stage of its development for the treatment of HER2 positive Breast Cancer.
Edit

Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 25 Mar 2025
The drug is being evaluated in Phase III Study to evaluate the efficacy and safety of Mosunetuzumab in ... Currently, it is in Phase III stage of clinical trial evaluation to treat Non-Hodgkin Lymphoma.

Article Search

tools
×
×
×
×